Donald McCaffrey - Resverlogix Corp CEO
| RVXCF Stock | USD 0.04 0.00 0.00% |
CEO
Mr. Donald J. McCaffrey is Chairman of the Board, President, Chief Executive Officer, Secretary of Resverlogix Corporationration He has almost 30 years of experience in drug discovery and development, and international conference and tradeshow management across multiple industries, including biotechnology. since 2016.
| Tenure | 8 years |
| Phone | 403 254 9252 |
| Web | https://www.resverlogix.com |
Resverlogix Corp Management Efficiency
The company has return on total asset (ROA) of (0.9632) % which means that it has lost $0.9632 on every $100 spent on assets. This is way below average. Resverlogix Corp's management efficiency ratios could be used to measure how well Resverlogix Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | CEO Age | ||
| FACC Facp | NewAmsterdam Pharma | 67 | |
| Adrian Gottschalk | Foghorn Therapeutics | 48 | |
| Rostislav Raykov | Fennec Pharmaceuticals | 48 | |
| BAO BCh | Eliem Therapeutics | 48 | |
| Richard Adcock | Immunitybio | 55 | |
| Brian Pedlar | Covalon Technologies | N/A | |
| Samuel MBA | Enliven Therapeutics | 38 | |
Management Performance
| Return On Asset | -0.96 |
Resverlogix Corp Leadership Team
Elected by the shareholders, the Resverlogix Corp's board of directors comprises two types of representatives: Resverlogix Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resverlogix. The board's role is to monitor Resverlogix Corp's management team and ensure that shareholders' interests are well served. Resverlogix Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resverlogix Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald McCaffrey, Co-Founder, CEO and President Secretary and Director | ||
| Ewelina Kulikowski, Chief Officer | ||
| Sarah Zapotichny, Director Communications | ||
| Michael MD, VP Devel |
Resverlogix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Resverlogix Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.96 | |||
| Current Valuation | 36.3 M | |||
| Shares Outstanding | 265.27 M | |||
| Shares Owned By Insiders | 44.51 % | |||
| Price To Earning | 11.36 X | |||
| EBITDA | (22.93 M) | |||
| Net Income | (24.77 M) | |||
| Cash And Equivalents | 42 K | |||
| Total Debt | 53.27 M | |||
| Current Ratio | 0.14 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Resverlogix Pink Sheet
Resverlogix Corp financial ratios help investors to determine whether Resverlogix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resverlogix with respect to the benefits of owning Resverlogix Corp security.